46 related articles for article (PubMed ID: 22999893)
1. Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Kemp DE; Karayal ON; Calabrese JR; Sachs GS; Pappadopulos E; Ice KS; Siu CO; Vieta E
Eur Neuropsychopharmacol; 2012 Feb; 22(2):123-31. PubMed ID: 21798721
[TBL] [Abstract][Full Text] [Related]
2. Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.
Tocco M; Newcomer JW; Mao Y; Pikalov A
CNS Spectr; 2023 Dec; 28(6):680-687. PubMed ID: 36961124
[TBL] [Abstract][Full Text] [Related]
3. The true effect of lithium is hard to determine.
Nielsen RE; Licht RW
BJPsych Open; 2023 Oct; 9(6):e187. PubMed ID: 37822221
[TBL] [Abstract][Full Text] [Related]
4. Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence matters.
Yatham LN; Schaffer A; Kessing LV; Miskowiak K; Kapczinski F; Vieta E; Post RM; Berk M
Bipolar Disord; 2024 Jun; 26(4):313-316. PubMed ID: 38664598
[No Abstract] [Full Text] [Related]
5. Addressing methodological concerns in omega-3 trial for bipolar disorder relapse prevention.
Zailani H; Chang JP; Chiu WC; Chang CJ; Su KP
Psychiatry Res; 2024 Jul; 337():115947. PubMed ID: 38733931
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.
Sachs GS; Vanderburg DG; Edman S; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1420-5. PubMed ID: 23218158
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
Kemp DE; Gao K; Fein EB; Chan PK; Conroy C; Obral S; Ganocy SJ; Calabrese JR
Bipolar Disord; 2012 Nov; 14(7):780-9. PubMed ID: 23107222
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
[TBL] [Abstract][Full Text] [Related]
11. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
12. Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.
Bowden CL; Karayal ON; Schwartz JH; Gundapaneni BK; O'Gorman C
J Affect Disord; 2013 Jan; 144(1-2):171-5. PubMed ID: 22999893
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.
Citrome L
Expert Rev Neurother; 2010 Jul; 10(7):1031-7. PubMed ID: 20586686
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.
Yatham LN; Fountoulakis KN; Rahman Z; Ammerman D; Fyans P; Marler SV; Baker RA; Carlson BX
J Affect Disord; 2013 May; 147(1-3):365-72. PubMed ID: 23290791
[TBL] [Abstract][Full Text] [Related]
15. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
